ArticlePolymers2026
Development and Biological Evaluation of
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
background
methodsAME-loaded nanofibers were produced by electrospinning and evaluated for their physicochemical properties, antioxidant activity, antimicrobial effects, antiproliferative potential, and molecular interactions with epidermal growth factor receptor (EGFR).
resultsAME incorporation increased the viscosity from 0.66 to 1.54 Pa·s and the fiber diameter from 0.39 to 0.84 μm while reducing the contact angle from 39.71° to 28.83°. The total phenolic content increased from 19.365 to 48.775 mg GAE/g, and the antioxidant capacity increased from 2.852 to 7.880 mg TE/g. At 500 μg/mL, AME reduced the maximum growth rate of
conclusionsAME-loaded nanofibers are potential sustainable products for health applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.